CSPC Pharmaceutical Group Ltd.

In News

AstraZeneca strikes deal for up to $18.5 billion to license weight-loss drugs from China's CSPC - Reuters

Reuters - Jan 30, 2026

Guojin Securities: Dual drivers of innovation and internationalization; initiates 'Buy' rating on CSPC Pharma (01093) - Moomoo

Moomoo - Jun 18, 2026

Cai succeeding Zhang as head of CSPC - biocentury.com

biocentury.com - Dec 19, 2025

CSPC Pharma (01093): The marketing authorization application for Secukinumab Injection has been accepted by the National Medical Products Administration. - 富途牛牛

富途牛牛 - Jun 18, 2026

Three Reputable Pharmaceutical Intermediate Manufacturers in China 2026: Powering Global Drug Development - EIN News

EIN News - Jun 10, 2026

Once‑Monthly Semaglutide And HER2 Data Could Be A Game Changer For CSPC Pharmaceutical Group (SEHK:1093) - simplywall.st

simplywall.st - Jun 15, 2026

CSPC’s SYS-6063 gains Chinese trial clearance for SLE - BioWorld News

BioWorld News - Jun 03, 2026

Astra Signs Obesity Deal With CSPC Worth Up to $18.5 Billion - Bloomberg.com

Bloomberg.com - Jan 30, 2026

New Combination for HER2+ Breast Cancer Meets Phase 3 Trial Goal - Cure Today

Cure Today - Apr 01, 2026

CSPC Pharmaceutical Group's Q1 Net Profit Tumbles as Sharp Decline in BD Revenue Drags Down Performance - 36 Kr

36 Kr - May 28, 2026

CSPC Pharmaceutical Group Limited Announces Highly Selective KAT6 Inhibitor SYH2095 Tablets Obtain Clinical Trial Approval In China - marketscreener.com

marketscreener.com - May 18, 2026

CSPC Pharma (01093): The trustee has purchased a total of 2.8 million shares under the share award scheme. - Moomoo

Moomoo - Jun 16, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment